News
Publication of interim report January – March 2026
OSLO, NORWAY – May 28, 2026: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the interim report for the…
Minutes of Annual General Meeting
OSLO, NORWAY – 20 May 2026: The Annual General Meeting in Genetic Analysis AS (the “Company”) was held on Wednesday…
Genetic Analysis granted a U.S. patent for companion diagnostic related to IBS treatment response
OSLO, NORWAY – 7 May 2026: Genetic Analysis AS (“GA” or “the Company”) announces today the United States Patent And…
Notice of Annual General Meeting
OSLO, NORWAY – 5 May 2026: Notice is hereby served that the annual general meeting in Genetic Analysis AS (the…
Genetic Analysis AS publishes Annual Report 2025
OSLO, NORWAY – 4 May 2026: Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the Annual Report for the…
Genetic Analysis to attend DDW congress in Chicago
OSLO, NORWAY, April 30, 2026: Microbiome DX company Genetic Analysis AS (“GA”) announces its attendance at Digestive Disease Week (DDW) congress…
Genetic Analysis AS launches AInsight for AI-assisted interpretation of GA-map® Dysbiosis Test results
OSLO, NORWAY – March 12: Genetic Analysis AS (“GA” or “the Company”) today announces the launch of GA-map® Dysbiosis Test…
Publication of year-end report 2025
OSLO, NORWAY – February 27, 2026: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the year-end report for 2025….
Genetic Analysis AS further strengthens IP portfolio with patent approval in the United States
OSLO, NORWAY – February 19, 2026: Genetic Analysis AS (“GA” or “the Company”) announces that its patent application US2017/0369941 has…
Microbiome Dx Genetic Analysis announces important patent approval enhancing the use of GA-map® in Canada
OSLO, NORWAY – February 12, 2026: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that its important…
Publication of interim report Q3 2025
OSLO, NORWAY – November 27, 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the interim report for Q3,…
Genetic Analysis AS announces milestone in the IBD diagnostic test development project – completion of biomarker panel for GA-map® IBD Precision Dx
OSLO, NORWAY – 17 November 2025: Microbiome DX company Genetic Analysis AS (“GA”) is pleased to announce the completion of…
Genetic Analysis attends the Biomarkers & Precision Medicine congress in London
OSLO, NORWAY, September 26, 2025: Microbiome DX company Genetic Analysis AS (“GA”) announces its attendance at the Biomarkers & Precision Medicine…
Genetic Analysis AS launches the GA-map® MHI GutHealth reagent kit
OSLO, NORWAY – 24 September 2025: Microbiome DX company Genetic Analysis AS (“GA”) announces the launch of a novel Research…
Publication of Half-year report 2025
OSLO, NORWAY – August 27 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the half-year report for H1,…